Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,966.00p
   
  • Change Today:
      8.00p
  • 52 Week High: 2,205.00p
  • 52 Week Low: 1,722.00p
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 9,484
  • Market Cap: £4,362.26m
  • RiskGrade: 125

RBC Capital lifts Hikma price target, reiterates 'outperform'

By Michele Maatouk

Date: Wednesday 03 May 2023

LONDON (ShareCast) - (Sharecast News) - RBC Capital Markets lifted its price target on Hikma Pharmaceuticals on Wednesday to 2,050p from 1,950p as it reiterated its 'outperform' rating.
The bank noted that price erosion is moderating in the US generics market largely due to improving supply side dynamics.

"As a result Hikma has raised guidance for the generics division to close to 20% revenue growth from low double digits.

"However, exchange rates in the MENA region have deteriorated further (particularly Egypt) which will negatively impact the branded division.

"We update our model for improved pricing in generics and latest exchange rates in MENA, resulting in modest forecast changes."

At 1255 BST, the shares were up 2.3% at 1,873.50p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,966.00p
Change Today 8.00p
% Change 0.41 %
52 Week High 2,205.00p
52 Week Low 1,722.00p
Volume 9,484
Shares Issued 221.89m
Market Cap £4,362.26m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.18% below the market average51.18% below the market average51.18% below the market average51.18% below the market average51.18% below the market average
21.57% below the sector average21.57% below the sector average21.57% below the sector average21.57% below the sector average21.57% below the sector average
Price Trend
56.56% above the market average56.56% above the market average56.56% above the market average56.56% above the market average56.56% above the market average
69.81% above the sector average69.81% above the sector average69.81% above the sector average69.81% above the sector average69.81% above the sector average
Income
8.95% above the market average8.95% above the market average8.95% above the market average8.95% above the market average8.95% above the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Growth
36.86% below the market average36.86% below the market average36.86% below the market average36.86% below the market average36.86% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 21-Mar-24 10-Aug-23
Paid 03-May-24 15-Sep-23
Amount 47.00¢ 25.00¢

Trades for 17-Jun-2024

Time Volume / Share Price
09:17 96 @ 1,966.00p
09:17 47 @ 1,966.00p
09:17 60 @ 1,966.00p
09:17 44 @ 1,966.00p
09:17 151 @ 1,966.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page